Literature DB >> 15115395

Structure-function relationships of multidrug resistance P-glycoprotein.

Ilza K Pajeva1, Christoph Globisch, Michael Wiese.   

Abstract

The direct structure-function relationships of P-glycoprotein (P-gp) are presently unknown. In this paper two P-gp models are described: a homology model based on the Escherichia coli MsbA lipid transporter and a model based on the cross-linking results of Loo and Clarke. The pharmacophore pattern for the H-site (Hoechst 33342) is derived and binding sites on the transmembrane domains TM5 and TM11 are identified. Binding sites of rhodamines are also proposed on TM6 and TM12 in accordance with the published data. Location of the binding sites is opposite in both models, suggesting that TMs undergo rotation exposing the substrate bound from the membrane to the pore. It has been concluded that the models derived represent two different functional states of P-gp corresponding to nucleotide-free and nucleotide-bound P-gp. A qualitative correspondence to the P-gp crystallographic structure at 20 A resolution is found. A hypothesis is proposed about rearrangement of TMs upon state transition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115395     DOI: 10.1021/jm031009p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).

Authors:  Alexandra Orchard; Gregory A Schamerhorn; Brandon D Calitree; Geri A Sawada; Tip W Loo; M Claire Bartlett; David M Clarke; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2012-06-07       Impact factor: 3.641

Review 2.  Structure-activity relationships of tariquidar analogs as multidrug resistance modulators.

Authors:  Ilza K Pajeva; Michael Wiese
Journal:  AAPS J       Date:  2009-06-06       Impact factor: 4.009

Review 3.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

4.  Understanding polyspecificity within the substrate-binding cavity of the human multidrug resistance P-glycoprotein.

Authors:  Lorena Martinez; Ophélie Arnaud; Emilie Henin; Houchao Tao; Vincent Chaptal; Rupak Doshi; Thibault Andrieu; Sébastien Dussurgey; Michel Tod; Attilio Di Pietro; Qinghai Zhang; Geoffrey Chang; Pierre Falson
Journal:  FEBS J       Date:  2014-01-17       Impact factor: 5.542

5.  Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.

Authors:  Michael K Gannon; Jason J Holt; Stephanie M Bennett; Bryan R Wetzel; Tip W Loo; M Claire Bartlett; David M Clarke; Geri A Sawada; J William Higgins; Gregory Tombline; Thomas J Raub; Michael R Detty
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

6.  Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.

Authors:  Pär Matsson; Jenny M Pedersen; Ulf Norinder; Christel A S Bergström; Per Artursson
Journal:  Pharm Res       Date:  2009-05-07       Impact factor: 4.200

7.  Discovery of novel antitumor antimitotic agents that also reverse tumor resistance.

Authors:  Aleem Gangjee; Jianming Yu; Jean E Copper; Charles D Smith
Journal:  J Med Chem       Date:  2007-06-14       Impact factor: 7.446

8.  99mTc-Sestamibi, a sensitive probe for in vivo imaging of P-glycoprotein inhibition by modulators and mdr1 antisense oligodeoxynucleotides.

Authors:  Veronika Jekerle; Jing-Hung Wang; Deborah A Scollard; Raymond M Reilly; Michael Wiese; Micheline Piquette-Miller
Journal:  Mol Imaging Biol       Date:  2006 Nov-Dec       Impact factor: 3.484

9.  Catalytic transitions in the human MDR1 P-glycoprotein drug binding sites.

Authors:  John G Wise
Journal:  Biochemistry       Date:  2012-06-12       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.